Microalbuminuria
From Wikipedia, the free encyclopedia
| ICD-10 | |
|---|---|
| ICD-9 | 791.0 |
| MedlinePlus | 003591 |
Microalbuminuria occurs when a malfunctioning kidney leaks small amounts of albumin into the urine. In other words, there is an abnormally high permselectivity for albumin in the renal glomerulus.
Contents |
[edit] Diagnosis
The level of albumin protein produced by Microalbuminuria cannot be detected by urine dipstick methods. A microalbumin urine test determines the presence of the albumin in urine. In a properly functioning body, albumin is not normally present in urine because it is filtered from the bloodstream by the kidneys.
Microalbuminuria is diagnosed either on 24-hour urine collections (20 to 200 µg/min) or, more commonly, if elevated concentrations (30 to 300mg/L) on at least two occasions.[1]. An Albumin level above these values is called "macroalbuminuria", or sometimes just albuminuria.
To compensate for the variable possible urine concentration on spot-check samples, it is more typical in the United Kingdom to compare the amount of albumin in the sample against its concentration of creatinine. This is termed the Albumin/creatinine ratio (ACR) and microalbuminuria is defined as ACR ≥2.5 mg/mmol (male) or ≥3.5 mg/mmol(female).[2]
[edit] Significance
- an indicator of subclinical cardiovascular disease
- marker of vascular endothelial dysfunction
- an important prognostic marker for kidney disease
- increasing microalbuminuria level during the first 48 hours after admission to an intensive care unit predicts elevated risk for acute respiratory failure , multiple organ failure , and overall mortality
[edit] See also
[edit] References
- Abid O, Sun Q, Sugimoto K, Mercan D, Vincent JL (2001). "Predictive value of microalbuminuria in medical ICU patients: results of a pilot study". Chest 120 (6): 1984–8. PMID 11742932.
- Andersen S, Blouch K, Bialek J, Deckert M, Parving HH, Myers BD (2000). "Glomerular permselectivity in early stages of overt diabetic nephropathy". Kidney Int. 58 (5): 2129–37. doi:. PMID 11044234.
- Heart Outcomes Prevention Evaluation Study Investigators (2000). "Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy.". Lancet 355 (9200): 253–9. PMID 10675071.
- Lemley KV, Abdullah I, Myers BD, et al (2000). "Evolution of incipient nephropathy in type 2 diabetes mellitus". Kidney Int. 58 (3): 1228–37. doi:. PMID 10972685.
- Lièvre M, Marre M, Chatellier G, et al (2000). "The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group". Controlled clinical trials 21 (4): 383–96. PMID 10913814.
- Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P (2001). "The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes". N. Engl. J. Med. 345 (12): 870–8. PMID 11565519.
[edit] Footnotes
- ^ Person—microalbumin level (measured), total micrograms per minute N[NNN.N]. Retrieved on 2007-07-05.
- ^ Proteinuria. UK Renal Association (Dec 15, 2005).
[edit] External links
|
|||||||||||
